The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Abstract
Recent investigations of atherosclerosis have focused on inflammation, providing new insight into mechanisms of disease. Inflammatory cytokines involved in vascular inflammation stimulate the generation of endothelial adhesion molecules, proteases, and other mediators, which may enter the circulation in soluble form. These primary cytokines also induce production of the messenger cytokine interleukin-6, which stimulates the liver to increase production of acute-phase reactants such as C-reactive protein. In addition, platelets and adipose tissue can generate inflammatory mediators relevant to atherothrombosis. Despite the irreplaceable utility of plasma lipid profiles in assessment of atherosclerotic risk, these profiles provide an incomplete picture. Indeed, many cardiovascular events occur in individuals with plasma cholesterol concentrations below the National Cholesterol Education Program thresholds of 200 mg/dL for total cholesterol and 130 mg/dL for low-density lipoprotein (LDL) cholesterol. The concept of the involvement of inflammation in atherosclerosis has spurred the discovery and adoption of inflammatory biomarkers for cardiovascular risk prediction. C-reactive protein is currently the best validated inflammatory biomarker; in addition, soluble CD40 ligand, adiponectin, interleukin 18, and matrix metalloproteinase 9 may provide additional information for cardiovascular risk stratification and prediction. This review retraces the biology of atherothrombosis and the evidence supporting the role of inflammatory biomarkers in predicting primary cardiovascular events in this biologic context.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has now become clear that low-grade chronic inflammation is a key player in the pathogenesis of most CNCDs.”
From Exercise as a Mean to Control Low‐Grade Systemic Inflammation (2008) · cites this paper as [6]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Self-citationInflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Self-citationPearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Flagged first, then by citations
Research works printed but not linked: 11
- 2004, Am J Med, 116 Suppl 6A, 9S
- 1996, Atherosclerosis, 124 Suppl, S1
- 1998, Am J Pathol, 152, 199
- 1992, Am J Pathol, 140, 301
- 2006, J Clin Invest, 116, 59
- 1993, Am J Pathol, 143, 1551
- 2007, Arterioscler Thromb Vasc Biol, 27, e302
- 2006, Atherosclerosis
- 2007, Am J Epidemiol, 165, 164
- 2007, Arterioscler Thromb Vasc Biol
- 2001, Clin Chem Lab Med, 39, 380
Cited by
Sorted by citations
Items 301–400 of 923
Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus
Haymana, C., Sonmez, A., Tapan, S., Safer, U., Celebi, G., Ozturk, O., Genç, H., Doğru, T., Tasci, I., Erdem, G., et al. (2010) · Endocrine · doi:10.1007/s12020-010-9334-4 · Cited by 33
Meng, L., Tang, Y., Ni, C., Yang, M. H., Song, H., Wang, G., Li, Y.-Z., Zhang, M., & Li, D. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.06.011 · Cited by 34
Younis, A., Eskenazi, D., Goldkorn, R., Leor, J., Naftali‐Shani, N., Fisman, E. Z., Tenenbaum, A., Goldenberg, I., & Klempfner, R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0551-5 · Cited by 32
Lysosome Function in Cardiovascular Diseases
Bhat, O. M., & Li, P. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000373 · Cited by 32
Ho, S., Xu, D., Wong, M. S., & Li, H. (2016) · Chemical Science · doi:10.1039/c5sc04115e · Cited by 31
Zheng, G., Chen, H., & Xiong, S.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034839 · Cited by 32
Wei, R., Lee, M., Lee, B., Oh, C., Choi, C.-G., & Kim, H. (2016) · Journal of Applied Phycology · doi:10.1007/s10811-016-0847-y · Cited by 31
Wu, H., Pang, H., Chen, Y.-P., Huang, L., Liu, H., Zheng, Y., Sun, C., Zhang, G., & Wang, G. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7858094 · Cited by 31
Hua, Z., Ma, K., Liu, S., Yue, Y., Cao, H., & Li, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117334 · Cited by 30
Weinmayr, G., Schulz, H., Klenk, J., Denkinger, M. D., Duran‐Tauleria, E., Köenig, W., Dallmeier, D., Rothenbacher, D., The ActiFE Study Group, Böhm, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68372-w · Cited by 31
Calza, L., Manfredi, R., & Verucchi, G. (2010) · AIDS · doi:10.1097/qad.0b013e328337afdf · Cited by 30
Kanwar, R. K., Chaudhary, R., Tsuzuki, T., & Kanwar, J. R. (2012) · Nanomedicine · doi:10.2217/nnm.12.46 · Cited by 30
Darabi, F., Aghaei, M., Movahedian, A., Pourmoghadas, A., & Sarrafzadegan, N. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2805-z · Cited by 30
Amrita, J., Mahajan, M., Bhanwer, A. J. S., & Mohan, G. (2016) · Biochemistry Research International · doi:10.1155/2016/6157605 · Cited by 29
Ye, Z., Li, Y., Liu, G., Qi, X., & Cao, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5355 · Cited by 29
Park, J., Bae, J.-J., & Lee, J. (2021) · Healthcare · doi:10.3390/healthcare9060711 · Cited by 28
Novel predictive risk factor for erectile dysfunction: Serum high‐sensitivity C‐reactive protein
Liu, G., Zhang, Y., Zhang, W., Wu, X., Jiang, H., Huang, H., & Zhang, X. (2022) · Andrology · doi:10.1111/andr.13206 · Cited by 29
The Vulnerable Plaque: the Real Villain in Acute Coronary Syndromes
Liang, M. M.-C., Puri, A., & Devlin, G. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010123 · Cited by 29
Arsenault, B. J., Pîbarot, P., & Després, J. (2008) · Cardiology · doi:10.1159/000165919 · Cited by 28
Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine
Domeij, H., Hua, X., Su, J., Bäcklund, A., Yan, Z.-Q., Frostegård, A. G., Haeggström, J. Z., Modéer, T., & Frostegård, J. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.01.004 · Cited by 29
Bock, K. W., & Köhle, C. (2010) · Biological Chemistry · doi:10.1515/bc.2010.065 · Cited by 30
Should C-Reactive Protein Be a Target of Therapy?
Oh, J., Teoh, H., & Leiter, L. A. (2011) · Diabetes Care · doi:10.2337/dc11-s211 · Cited by 30
VNN1 promotes atherosclerosis progression in apoE−/− mice fed a high-fat/high-cholesterol diet
Hu, Y., Wu, S.-G., Zhao, J., Ma, X., Lu, J., Xiu, J., Zhang, Y., Huang, C., Qiu, Y., Sha, Y.-H., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m065565 · Cited by 29
Dosh, K., Berger, P. B., Marso, S. P., Lente, F. V., Brennan, D. M., Charnigo, R. J., Topol, E. J., & Steinhubl, S. R. (2009) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.109.879312 · Cited by 31
Pedrinelli, R. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4800 · Cited by 29
Whole blood gene expression and interleukin-6 levels
Lin, H., Joehanes, R., Pilling, L. C., Dupuis, J., Lunetta, K. L., Ying, S., Benjamin, E. J., Hernandez, D. G., Singleton, A., Melzer, D. R., et al. (2014) · Genomics · doi:10.1016/j.ygeno.2014.10.003 · Cited by 28
Erturan, İ., Köroğlu, B. K., Adiloğlu, A. K., Ceyhan, A. M., Akkaya, V. B., Tamer, N., Başak, P. Y., Korkmaz, S., Ersoy, İ. H., & Kılınç, O. Ö. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12397 · Cited by 28
KONES, R. J. (2009) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944709337056 · Cited by 29
Relevance of urocortins to cardiovascular disease
Emeto, T. I., Moxon, J. V., Rush, C. M., Woodward, L., & Golledge, J. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.06.002 · Cited by 28
Kim, H. J., Son, J. E., Kim, J. H., Lee, C. C., Yang, H. S., Yaghmoor, S., Ahmed, Y. M., Yousef, J. M., Abualnaja, K. O., Al‐Malki, A. L., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26138 · Cited by 28
Du, X., & Lu, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26819 · Cited by 28
Serban, C., & Dragan, S. R. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282004140213145806 · Cited by 27
Kanwar, R. K., Chaudhary, R., Tsuzuki, T., & Kanwar, J. R. (2012) · Nanomedicine · doi:10.2217/nnm.12.57 · Cited by 27
Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity
Vuilleumier, N., Montecucco, F., & Hartley, O. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i5.314 · Cited by 27
Bo’, C. D., Cao, Y., Roursgaard, M., Riso, P., Porrini, M., Loft, S. H., & Möller, P. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0835-z · Cited by 28
Genetic Architecture of the Pro-Inflammatory State in an Extended Twin-Family Design
Neijts, M., van Dongen, J., Kluft, C., Boomsma, D. I., Willemsen, G. A. H. M., & de Geus, E. J. C. (2013) · Twin Research and Human Genetics · doi:10.1017/thg.2013.58 · Cited by 27
Inflammation and Depression: A Nervous Plea for Psychiatry to Not Become Immune to Interpretation
Konsman, J. P. (2019) · Pharmaceuticals · doi:10.3390/ph12010029 · Cited by 27
Garcia-Bello, J. A., Gómez-Díaz, R. A., Contreras-Rodríguez, A., Talavera, J. O., Mondragón-González, R., Sanchez-Barbosa, L., Diaz-Flores, M., Valladares-Salgado, A., Gallardo, J. M., Aguilar-Kitsu, A., et al. (2014) · Pediatric Nephrology · doi:10.1007/s00467-013-2626-1 · Cited by 26
Jabrah, D., Rossi, R., Molina, S., Douglas, A., Pandit, A. S., McCarthy, R., Gilvarry, M., Ceder, E., Fitzgerald, S. T., Dunker, D., et al. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.12.005 · Cited by 26
The Association of Serum Neutrophil Markers and Acute Coronary Syndrome
Alfakry, H., Sinisalo, J. P., Paju, S., Nieminen, M. S., Valtonen, V., Tervahartiala, T. I., Pussinen, P. J., & Sorsa, T. A. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02718.x · Cited by 26
Vaucher, J., Marques-Vidal, P. M., Waeber, G., & Vollenweider, P. (2014) · Cytokine · doi:10.1016/j.cyto.2014.01.003 · Cited by 26
Janckila, A. J., Lin, H.-F., Wu, Y., Ku, C., Yang, S., Lin, W., Lee, S.-H., Yam, L. T., & Chao, T.-Y. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.01.035 · Cited by 26
Jabir, N. R., Firoz, C. K., Kamal, M. A., Damanhouri, G. A., Alama, M. N., Alzahrani, A. S., Almehdar, H. A., & Tabrez, S. S. M. (2016) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22092 · Cited by 26
Tuberculosis increases the risk of peripheral arterial disease: A nationwide population‐based study
Wang, S., Chien, W., Chung, C., Lin, F., Peng, C., Chian, C., & Shen, C. (2017) · Respirology · doi:10.1111/resp.13117 · Cited by 26
Cheow, E. S. H., Cheng, W. C., Yap, T., Dutta, B., Lee, C. N., de Kleijn, D. P. V., Sorokin, V. A., & Sze, S. K. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00651 · Cited by 26
Cho, D., Song, I., Choi, J., & Gwon, J. G. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.012 · Cited by 26
Yan, N., Wang, L., Li, Y., Wang, T., Yang, L., Yan, R., Wang, H., & Jia, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254321 · Cited by 25
Characterization of Tibetan kefir grain-fermented milk whey and its suppression of melanin synthesis
Chen, M.-Y., Wu, H., Chen, F., Wang, Y., Chou, D.-L., Wang, G.-H., & Chen, Y.-P. (2022) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2022.02.006 · Cited by 26
Gwon, W., Lee, B., Joung, E., Choi, M.-W., Yoon, N., Shin, T., Oh, C., & Kim, H. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b04050 · Cited by 26
High Density Lipoprotein: Assembly, Structure, Cargo, and Functions
Murphy, A. J. (2013) · ISRN Physiology · doi:10.1155/2013/186365 · Cited by 26
Secretory Phospholipase A2, Group IIA Is a Novel Serum Amyloid A Target Gene
Sullivan, C. P., Seidl, S. E., Rich, C. B., Raymondjean, M., & Schreiber, B. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070565 · Cited by 26
Katagiri, M., Takahashi, M., Doi, K., Myojo, M., Kiyosue, A., Ando, J., Hirata, Y., & Komuro, I. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0776-8 · Cited by 26
5-Lipoxygenase-mediated Endogenous DNA Damage
Jian, W., Lee, S. H., Williams, M. V., & Blair, I. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011841 · Cited by 26
Saffi, M. A. L., Furtado, M. V., Montenegro, M. M., Ribeiro, I. W. J., Kampits, C., Rabelo, E. R., Polanczyk, C. A., Rõsing, C. K., & Haas, A. N. (2013) · Trials · doi:10.1186/1745-6215-14-283 · Cited by 26
Hung, W., Yu, T., Hsu, C., Lu, L.-F., Chung, F., Tsai, I., Lu, Y., Houng, J., Lee, Y., & Wang, C.-P. (2015) · Clinical and investigative medicine · doi:10.25011/cim.v38i3.22705 · Cited by 25
Pro-inflammatory genetic profile and familiarity of acute myocardial infarction
Ianni, M., Callegari, S., Rizzo, A., Pastori, P., Moruzzi, P., Corradi, D., Porcellini, E., Campo, G. C., Ferrari, R., Ferrario, M., et al. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-14 · Cited by 25
Tork, O. M., Khaleel, E. F., & Abdel-Maksoud, O. M. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8271 · Cited by 25
Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease
Weiss, T. W., Seljeflot, I., Hjerkinn, E. M., & Arnesen, H. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02717.x · Cited by 25
Regulation of Inflammation-Mediated Chronic Diseases by Botanicals
Sung, B., Prasad, S., Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2012) · Advances in botanical research · doi:10.1016/b978-0-12-394591-4.00003-9 · Cited by 28
Pioglitazone and mechanisms of CV protection
Erdmann, E., & Wilcox, R. G. (2009) · QJM · doi:10.1093/qjmed/hcp168 · Cited by 25
Interleukin-6 Release after Carotid Artery Stenting and Periprocedural New Ischemic Lesions
Abe, Y., Sakaguchi, M., Furukado, S., Fujinaka, T., Sakoda, S., Yoshimine, T., & Kitagawa, K. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.250 · Cited by 25
Mäkelä, K.-M., Seppälä, I., Hernesniemi, J. A., Lyytikäinen, L., Oksala, N., Kleber, M. E., Scharnagl, H., Grammer, T. B., Baumert, J., Thorand, B., et al. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.964965 · Cited by 27
Emerging inflammatory markers for assessing coronary heart disease risk
Corson, M. A. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0065-1 · Cited by 25
Liu, W., Liu, Y., Jiang, H., Ding, X., Zhu, R., Li, B., & Zhao, Y. (2013) · Inflammation · doi:10.1007/s10753-013-9647-6 · Cited by 25
Detection of atherosclerotic plaques in ApoE-deficient mice using 99mTc-duramycin
Liu, Z., Larsen, B. T., Lerman, L. O., Gray, B. D., Barber, C., Hedayat, A. F., Zhao, M. F., Furenlid, L. R., Pak, K. Y., & Woolfenden, J. M. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.05.007 · Cited by 25
Lipskaia, L., Hadri, L., López, J. J., Hajjar, R. J., & Bobe, R. (2013) · Current Vascular Pharmacology · doi:10.2174/1570161111311040010 · Cited by 25
Nair, V., Bandyopadhyay, P., Kundu, D., & Das, S. (2016) · Journal of Indian Society of Periodontology · doi:10.4103/0972-124x.183098 · Cited by 25
Tumor Necrosis Factor‐Alpha Gene Promoter Region Polymorphism and the Risk of Coronary Heart Disease
Asifa, G. Z., Liaquat, A., Murtaza, I., Kazmi, S. A. R., & Javed, Q. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/203492 · Cited by 24
Madsen, A. M., White, J. K., Markouch, A., Kadhim, S., de Jonge, N., Thilsing, T., Hansen, V. M., Bælum, J., Nielsen, J. L., Vogel, U. B., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110325 · Cited by 24
Role of mechanosensitive channels/receptors in atherosclerosis
Mukherjee, P., Rahaman, S. G., Goswami, R., Dutta, B., Mahanty, M., & Rahaman, S. O. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00396.2021 · Cited by 22
Yang, Y., Karampoor, S., Mirzaei, R., Бороздкин, Л. Л., & Zhu, P. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110546 · Cited by 24
Mahajan, N., Dhawan, V., Mahmood, S., Malik, S., & Jain, S. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.07.007 · Cited by 24
Pruijm, M. T., Schmidtko, J., Aho, A., Pagano, S., Roux‐Lombard, P., Teta, D., Burnier, M., & Vuilleumier, N. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2012.01102.x · Cited by 24
Raitoharju, E., Seppälä, I., Levula, M., Kuukasjärvi, P., Laurikka, J. O., Nikus, K. C., Huovila, A. J., Oksala, N., Klopp, N., Illig, T., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.005 · Cited by 24
KOO, H. J., Sohn, E., Pyo, S., Woo, H. G., Park, D. W., Ham, Y., Jang, S., Park, S.-Y., & Kang, S. C. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2112 · Cited by 24
Yu‐hai, G., & Zhao, Z. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2604 · Cited by 24
Odeberg, J., Freitag, M., Forssell, H. W., Vaara, I., Persson, M.-L., Odeberg, H., Halling, A., Råstam, L., & Lindblad, U. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009968 · Cited by 27
Quantification of Various Inflammatory Cells in Advanced Atherosclerotic Plaques
Paul, V. S. V. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19354.7879 · Cited by 24
Differential arterial and venous endothelial redox responses to oxidative stress
Shrestha, B., Prasai, P. K., Kaskas, A. M., Khanna, A., Letchuman, V., Letchuman, S., Alexander, J. S., Orr, A. W., Woolard, M. D., & Pattillo, C. B. (2018) · Microcirculation · doi:10.1111/micc.12486 · Cited by 24
Meza-Miranda, E. R., Rangel-Zúñiga, O. A., Marı́n, C., Pérez‐Martínez, P., Delgado‐Lista, J., Haro, C., Peña‐Orihuela, P. J., Jiménez-Morales, A. I., Malagón, M. M., Tinahones, F. J., et al. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0868-3 · Cited by 24
Atherosclerosis risk factors in systemic lupus erythematosus
Agarwal, S., Elliott, J. R., & Manzi, S. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0034-0 · Cited by 24
Glycemic index role on visceral obesity, subclinical inflammation and associated chronic diseases.
Pereira, P. F., de Almeida, C. D. G., & Alfenas, R. D. C. G. (2014) · PubMed · doi:10.3305/nh.2014.30.2.7506 · Cited by 26
Castellanos, M. I., Guillem‐Marti, J., Mas‐Moruno, C., Díaz‐Ricart, M., Escolar, G., Ginebra, M., Gil, F. J., Pegueroles, M., & Manero, J. M. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35988 · Cited by 23
Pharmacological modulation of vascular inflammation in atherothrombosis
Caterina, R. D., Massaro, M., Scoditti, E., & Carluccio, M. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05784.x · Cited by 23
Jefferis, B. J. M. H., Whincup, P. H., Welsh, P. I., Wannamethee, S. G., Rumley, A., LENNON, L. T., Thomson, A. G., Carson, C., Ebrahim, S. B. J., & Lowe, G. D. O. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.001 · Cited by 23
Baranowski, T., Kralisch, S., Bachmann, A., Lössner, U., Kratzsch, J., Blüher, M., Stümvoll, M., & Faßhauer, M. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1267917 · Cited by 24
Quercioli, A., Montecucco, F., Galan, K., Ratib, O. M., Roux‐Lombard, P., Pagano, S., Mach, F., Schindler, T. H., & Vuilleumier, N. (2012) · Mediators of Inflammation · doi:10.1155/2012/243158 · Cited by 23
Pi, C., Yuan, J., Liu, H., Zuo, Y., Feng, T., Zhan, C., Wu, J. Y., Ye, Y., Zhao, L., & Wei, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.04.171 · Cited by 23
Beavers, K. M., Serra, M. C., Beavers, D. P., Hudson, G. M., & Willoughby, D. S. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.0171 · Cited by 24
Dietary Patterns, Foods, Nutrients and Chronic Inflammatory Disorders
Casas, R. M., & Estruch, R. (2016) · Immunome Research · doi:10.4172/1745-7580.10000122 · Cited by 21
Circulating PGLYRP1 Levels as a Potential Biomarker for Coronary Artery Disease and Heart Failure
Han, Y., Hua, S., Chen, Y., Yang, W., Zhao, W., Huang, F., Qiu, Z., Yang, C., Jiang, J., Su, X., et al. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000996 · Cited by 22
Perivascular Adipose Tissue Oxidative Stress in Obesity
Man, A. W. C., Zhou, Y., Xia, N., & Li, H. (2023) · Antioxidants · doi:10.3390/antiox12081595 · Cited by 22
Gigante, B., Bennet, A. M., Leander, K., Vikström, M., & Fairé, U. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011300 · Cited by 22
Niida, T., Isoda, K., Kitagaki, M., Ishigami, N., Adachi, T. K., Matsubara, O., Takeda, K., Kishimoto, T., & Ohsuzu, F. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr323 · Cited by 22
Niu, Y., Weng, H., Zhang, C., Yuan, R., Yan, J.-Z., Meng, X., & Luo, J. (2015) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8365-7 · Cited by 22
de Matos, S. B., Meyer, R., & Lima, F. W. D. M. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21965 · Cited by 22
Sebastián, J. V. B., Sáez, G. T., Tormos, M. J., Hens, E., Terol, M. J., Bagán, L., Diaz‐Fernández, J., Lluch, A. M., & Camps, C. (2013) · Oral Diseases · doi:10.1111/odi.12150 · Cited by 22
Zykov, M. V., Барбараш, О. Л., Кашталап, В. В., Кутихин, А. Г., & Barbarash, L. S. (2016) · Heart & Lung · doi:10.1016/j.hrtlng.2016.03.007 · Cited by 22
Olive Oil: Antioxidant Compounds and Their Potential Effects over Health
Kabaran, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80993 · Cited by 23
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
Böcskei, R. M., Benczúr, B., Losonczy, G., Illyés, M., Cziráki, A., Müller, V., Bohács, A., & Bikov, A. (2019) · Lung · doi:10.1007/s00408-019-00211-w · Cited by 22
Metadata
- Authors
- Packard, R. R. S., & Libby, P.
- Affiliations
- Leducq Center for Cardiovascular Research, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
- Brigham and Women's Hospital (US)
- Corresponding author
- Libby, Peter
- ORCID
- Libby, Peter
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-01
- Volume
- 54
- Issue
- 1
- Pages
- 24-38
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2023647145
- Cited by
- 925
- References
- 169
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 10 · 2023: 20 · 2022: 19 · 2021: 39 · 2020: 44 · 2019: 39 · 2018: 37 · 2017: 39 · 2016: 61 · 2015: 69 · 2014: 65 · 2013: 93 · 2012: 81
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- atherosclerosis, vascular inflammation, inflammatory markers, cardiovascular risk prediction, C-reactive protein, interleukin-6, atherothrombosis, platelets, adipose tissue, soluble CD40 ligand, adiponectin, IL-18, MMP-9, endothelial adhesion molecules, acute phase proteins, low LDL cholesterol
- MeSH terms
- Cardiovascular Diseases, Humans, Inflammation, Risk, Biomarkers, Inflammation Mediators, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review